PL366232A1 - Protease inhibitors - Google Patents

Protease inhibitors

Info

Publication number: PL366232A1
Authority: PL; Poland
Prior art keywords: protease inhibitors; protease; inhibitors
Prior art date: 2000-11-22

Application number

PL01366232A

Other languages

Polish (pl)

Inventor

Robert W.Jr. Marquis

Daniel F. Veber

Dennis S. Yamashita

Original Assignee

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-22

Filing date

2001-11-19

Publication date

2005-01-24

2001-11-19 Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation

2005-01-24 Publication of PL366232A1 publication Critical patent/PL366232A1/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

PL01366232A 2000-11-22 2001-11-19 Protease inhibitors PL366232A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US25250800P	2000-11-22	2000-11-22
PCT/US2001/051647 WO2003053331A2 (en)	2000-11-22	2001-11-19	Protease inhibitors

Publications (1)

Publication Number	Publication Date
PL366232A1 true PL366232A1 (en)	2005-01-24

Family

ID=22956303

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01366232A PL366232A1 (en)	2000-11-22	2001-11-19	Protease inhibitors

Country Status (17)

Country	Link
EP (1)	EP1392657A4 (en)
JP (1)	JP2005513083A (en)
KR (1)	KR20040004445A (en)
CN (1)	CN1635903A (en)
AR (1)	AR034278A1 (en)
AU (1)	AU2001298052A1 (en)
BR (1)	BR0115473A (en)
CA (1)	CA2436850A1 (en)
CZ (1)	CZ20031403A3 (en)
HU (1)	HUP0301964A3 (en)
IL (1)	IL155997A0 (en)
MX (1)	MXPA03004542A (en)
NO (1)	NO20032328L (en)
PL (1)	PL366232A1 (en)
UY (1)	UY27032A1 (en)
WO (1)	WO2003053331A2 (en)
ZA (1)	ZA200303848B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030144175A1 (en)	1998-12-23	2003-07-31	Smithkline Beecham Corporation	Protease inhibitors
HUP0300068A2 (en)	2000-03-21	2003-05-28	Smithkline Beecham Corp	Protease inhibitors, their preparation, their use and pharmaceutical compositions containing them
MXPA02012442A (en) *	2000-06-14	2003-04-25	Smithkline Beecham Corp	Protease inhibitors.
EP2168600A1 (en)	2007-06-08	2010-03-31	Nippon Chemiphar Co., Ltd.	Therapeutic or prophylactic agent for cerebral aneurysm
JPWO2009054454A1 (en)	2007-10-24	2011-03-03	国立大学法人東京医科歯科大学	Modulator of signal transduction of Toll-like receptor containing cathepsin inhibitor as an active ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9916488A (en) *	1998-12-23	2001-10-09	Smithkline Beecham Corp	Protease inhibitors
HUP0300068A2 (en) *	2000-03-21	2003-05-28	Smithkline Beecham Corp	Protease inhibitors, their preparation, their use and pharmaceutical compositions containing them
MXPA02012442A (en) *	2000-06-14	2003-04-25	Smithkline Beecham Corp	Protease inhibitors.

2001
- 2001-11-19 PL PL01366232A patent/PL366232A1/en not_active Application Discontinuation
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/en not_active Application Discontinuation
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/en not_active Application Discontinuation
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/en not_active Withdrawn
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/en unknown
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/en unknown
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/en unknown
- 2001-11-19 EP EP01275089A patent/EP1392657A4/en not_active Withdrawn
- 2001-11-19 CA CA002436850A patent/CA2436850A1/en not_active Abandoned
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/en not_active Application Discontinuation
- 2001-11-19 IL IL15599701A patent/IL155997A0/en unknown
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-19 CN CNA018220533A patent/CN1635903A/en active Pending
- 2001-11-20 AR ARP010105409A patent/AR034278A1/en unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/en not_active Application Discontinuation
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/en unknown

Also Published As

Publication number	Publication date
NO20032328D0 (en)	2003-05-22
HUP0301964A3 (en)	2007-09-28
AR034278A1 (en)	2004-02-18
EP1392657A4 (en)	2004-03-10
BR0115473A (en)	2004-09-28
WO2003053331A3 (en)	2003-11-13
AU2001298052A1 (en)	2003-07-09
UY27032A1 (en)	2002-07-31
KR20040004445A (en)	2004-01-13
NO20032328L (en)	2003-07-02
EP1392657A2 (en)	2004-03-03
JP2005513083A (en)	2005-05-12
WO2003053331A2 (en)	2003-07-03
CZ20031403A3 (en)	2003-10-15
CN1635903A (en)	2005-07-06
CA2436850A1 (en)	2003-07-03
HUP0301964A2 (en)	2007-02-28
IL155997A0 (en)	2003-12-23
ZA200303848B (en)	2004-06-28
MXPA03004542A (en)	2003-09-10

Legal Events

Date	Code	Title	Description
2009-07-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
AU4344101A (en)	2001-10-03	Protease inhibitors
GB0125445D0 (en)	2001-12-12	Protease Inhibitors
IL215892A0 (en)	2011-12-29	Peptidomimetic protease inhibitors
IL153421A0 (en)	2003-07-06	Protease inhibitors
EP1235577A4 (en)	2003-04-09	Protease inhibitors
EP1232155A4 (en)	2002-11-20	Protease inhibitors
IL151087A0 (en)	2003-04-10	Protease inhibitors
EP1229915A4 (en)	2003-05-14	Protease inhibitors
EP1231921A4 (en)	2004-06-23	Protease inhibitors
EP1229912A4 (en)	2003-05-07	Protease inhibitors
EP1229914A4 (en)	2004-06-23	Protease inhibitors
EP1173429A4 (en)	2002-06-19	Protease inhibitors
EP1229911A4 (en)	2003-05-07	Protease inhibitors
HK1043534A1 (en)	2002-09-20	Protease inhibitors
EP1233771A4 (en)	2003-05-14	Protease inhibitors
EP1351930A4 (en)	2004-09-15	Protease inhibitors
EP1401453A4 (en)	2005-04-06	Protease inhibitors
EP1231923A4 (en)	2003-05-14	Protease inhibitors
HUP0301964A3 (en)	2007-09-28	Protease inhibitors
IL155961A0 (en)	2003-12-23	Cysteine protease inhibitors
EP1232154A4 (en)	2004-06-23	Protease inhibitors
EP1231922A4 (en)	2004-06-23	Protease inhibitors
AU6407701A (en)	2001-12-24	Serine protease inhibitors
GB0009123D0 (en)	2000-05-31	Protease inhibitor
ZA200207478B (en)	2003-10-08	Protease inhibitors.